BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 11240240)

  • 61. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
    Bartelink H; Roelofsen F; Eschwege F; Rougier P; Bosset JF; Gonzalez DG; Peiffert D; van Glabbeke M; Pierart M
    J Clin Oncol; 1997 May; 15(5):2040-9. PubMed ID: 9164216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity.
    Tanum G; Tveit KM; Karlsen KO
    Oncology; 1993; 50(1):14-7. PubMed ID: 8421594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal.
    Svensson C; Goldman S; Friberg B; Glimelius B
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):863-7. PubMed ID: 9652850
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidermoid carcinoma of the anal canal. A series of 276 cases.
    Papillon J; Montbarbon JF
    Dis Colon Rectum; 1987 May; 30(5):324-33. PubMed ID: 3568920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Radiochemotherapy in anal canal epidermoid cancer].
    Peiffert D
    Ann Chir; 2000 Oct; 125(8):717-25. PubMed ID: 11105342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
    Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma.
    Allal AS; Mermillod B; Roth AD; Marti MC; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1099-105. PubMed ID: 9392550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study.
    Vuong T; Devic S; Belliveau P; Muanza T; Hegyi G
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):823-31. PubMed ID: 12788191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.
    Peiffert D; Giovannini M; Ducreux M; Michel P; François E; Lemanski C; Mirabel X; Cvitkovic F; Luporsi E; Conroy T; Gérard JP;
    Ann Oncol; 2001 Mar; 12(3):397-404. PubMed ID: 11332154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
    Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
    Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].
    Dubois JB; Azria D; Ychou M
    Bull Cancer; 2003 Dec; 90(12):1107-10. PubMed ID: 14715430
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
    Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Squamous cell carcinoma of the anal margin: the university of Florida experience.
    Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
    Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.